EUVIMEDEUVIMED entdecken
Crossref

The p.T216R mutation of the thromboxane A2 receptor disrupts platelet function by selectively altering the G12/13 signaling pathway

Kevin Denis, Véronique Heim, Mathieu Fiore, Patricia Laeufer, Anita Eckly, Huguenin Yoann, Dominique Desprez, Pierre Mangin, Beatrice Hechler, Arnaud Dupuis, Catherine Strassel

Journal of Thrombosis and Haemostasis · 2026-08 · 24 (8) · 2849-2856

DOI: 10.1016/j.jtha.2026.03.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-08. Verfasst von Kevin Denis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Université de Strasbourg, INSERM, EFS Grand-Est, BPPS UMR-S 1255, FMTS, F-67065 Strasbourg, France. Hauptthemen laut MEDLINE: Receptors, Thromboxane A2, Prostaglandin H2, Blood Platelets, Signal Transduction, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The thromboxane A2 receptor (TBXA2R) is a platelet receptor that binds to 2 distinct G protein signaling pathways (Gq and Gα12/13) and plays a major role in platelet activation. Mutations in the TBXA2R gene can alter platelet aggregation and cause bleeding disorders. Until now, only mutations affecting the Gq pathway have been reported. OBJECTIVES: This study aimed to characterize a new TBXA2R gene mutation discovered in a family with moderate bleeding syndrome. METHODS: After identifying the mutation through gene sequencing, the function of the platelets was evaluated using aggregation tests after stimulation with the thromboxane analogue U46619, arachidonic acid, and collagen. The functional consequences of the mutation were then examined through the studies of intracellular calcium signaling and RhoA signaling pathway. RESULTS: Defective aggregation responses were observed when the platelets were stimulated by U46619, arachidonic acid, or collagen. In contrast to other described TBXA2R mutations, the p.T216R mutation did not affect the Gq signaling pathway that regulates intracellular calcium. Rather, it selectively impaired the Gα12/13 signaling pathway, which is associated with RhoA and myosin light chain activation, thereby affecting actin-myosin contractility. CONCLUSION: This study is the first to demonstrate the selective impact of TBXA2R mutation on Gα12/13-dependent signaling, providing new insights into the molecular mechanisms underlying platelet dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Thromboxane A2, Prostaglandin H2Blood PlateletsSignal TransductionMutationGTP-Binding Protein alpha Subunits, G12-G13HumansPlatelet Aggregation15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidrhoA GTP-Binding ProteinCalcium SignalingCollagenArachidonic AcidMaleFemaleDNA Mutational AnalysisCalciumGTP-Binding Protein alpha Subunits, Gq-G11

Stichwörter der Autor:innen

blood platelet disordershemorrhagic disordersreceptorsthromboxane A2

Substanzen

Receptors, Thromboxane A2, Prostaglandin H2GTP-Binding Protein alpha Subunits, G12-G1315-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidrhoA GTP-Binding ProteinCollagenArachidonic AcidRHOA protein, humanCalciumGTP-Binding Protein alpha Subunits, Gq-G11

Autor:innen und Institutionen

  • Université de Strasbourg, INSERM, EFS Grand-Est, BPPS UMR-S 1255, FMTS, F-67065 Strasbourg, France.
  • Service d'Hématologie Biologique, Centre de Référence des Pathologies Plaquettaires, CHU de Bordeaux, INSERM U1034, Pessac, France.
  • Centre de Ressources et de Compétences des Maladies Hémorragiques Constitutionnelles, CHU de Bordeaux, Bordeaux, France.
  • Centre de Ressources et de Compétences des Maladies Hémorragiques Constitutionnelles, CHU de Strasbourg, Strasbourg, France.
  • Université de Strasbourg, INSERM, EFS Grand-Est, BPPS UMR-S 1255, FMTS, F-67065 Strasbourg, France. Electronic address: catherine.strassel@efs.sante.fr.

Zitieren

APA

Denis, K., Heim, V., Fiore, M., Laeufer, P., Eckly, A., Yoann, H., Desprez, D., Mangin, P., Hechler, B., Dupuis, A., & Strassel, C. (2026). The p.T216R mutation of the thromboxane A2 receptor disrupts platelet function by selectively altering the G12/13 signaling pathway. Journal of Thrombosis and Haemostasis, 24(8), 2849-2856. https://doi.org/10.1016/j.jtha.2026.03.027

Vancouver

Denis K, Heim V, Fiore M, Laeufer P, Eckly A, Yoann H, et al. The p.T216R mutation of the thromboxane A2 receptor disrupts platelet function by selectively altering the G12/13 signaling pathway. Journal of Thrombosis and Haemostasis. 2026;24(8):2849-2856. doi:10.1016/j.jtha.2026.03.027

BibTeX
@article{Denis2026,
  author = {Denis, Kevin and Heim, Véronique and Fiore, Mathieu and Laeufer, Patricia and Eckly, Anita and Yoann, Huguenin and Desprez, Dominique and Mangin, Pierre and Hechler, Beatrice and Dupuis, Arnaud and Strassel, Catherine},
  title = {The p.T216R mutation of the thromboxane A2 receptor disrupts platelet function by selectively altering the G12/13 signaling pathway},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {8},
  pages = {2849--2856},
  doi = {10.1016/j.jtha.2026.03.027}
}
Kostenlos starten →